360º retinectomy effective for retinal detachment


Virectomy with 360º retinectomy can be beneficial for the treatment of complex retinal detachments

It has been demonstrated that virectomy with 360º retinectomy can be beneficial for the treatment of complex retinal detachments, from recent research published in Retina.

Dr Anton Kolomeyer et al., Institute of Ophthalmology and Visual Science, New Jersey Medical School, Newark, New Jersey, USA, reviewed the data of 41 eyes of 40 patients who underwent pars plana virectomy and 360º retinectomy for various reasons.

For 26 of the 41 eyes the main reason for surgery was retinal detachment after penetrating trauma. The outcome measures were complete retinal reattachment or attachment posterior to the scleral buckle. It was found that 11 eyes had recurrent retinal detachment and 7 received repeat pars plana virectomy with success in 6 of the eyes. The treatment was an anatomical success in 25 of 30 eyes and only 4 of the eyes had limited visual results.

The results show complex retinal detachment can be sufficiently managed by virectomy with 360º retinectomy.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.